IBP logo

Indo-Bangla Pharmaceuticals Limited Stock Price

DSE:IBP Community·৳1.5b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

IBP Share Price Performance

৳12.80
2.50 (24.27%)
৳12.80
2.50 (24.27%)
Price ৳12.80

IBP Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet with low risk.

3 Risks
0 Rewards

Indo-Bangla Pharmaceuticals Limited Key Details

৳221.2m

Revenue

৳182.5m

Cost of Revenue

৳38.6m

Gross Profit

৳64.3m

Other Expenses

-৳25.6m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
-0.22
17.47%
-11.59%
1.3%
View Full Analysis

About IBP

Founded
1954
Employees
127
CEO
A. F. M. Huq
WebsiteView website
www.indo-banglapharma.com

Indo-Bangla Pharmaceuticals Limited engages in the manufacture and sale of various medicines, medical preparations drugs, and chemicals in Bangladesh and internationally. The company’s principal products include Omeprazole, Esomeprazole, Dexamethasone, Domperidone, Metronidazole, Montelukast, Paracetamol, Sildenafil Citrate, and several other formulations. It markets its products in various forms, such as tablets, capsules. Indo-Bangla Pharmaceuticals Limited was founded in 1954 and is based in Dhaka, Bangladesh.

Recent IBP News & Updates

Recent updates

No updates